{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:55:20Z","timestamp":1792601720706,"version":"4.5.0"},"reference-count":42,"publisher":"MyJove Corporation","issue":"222","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68122","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:00:26Z","timestamp":1756508426000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease"],"prefix":"10.3791","author":[{"given":"Zeineb","family":"Fridhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Cherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Bourzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayma","family":"Dlimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannani","family":"Boukhawiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekri","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthi","family":"Duraisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Le Solliec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoufik","family":"Ghrairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Leprince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Masmoudi-Kouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"4","key":"ref1","first-page":"422","type":"journal-article","article-title":"MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies","volume":"21","author":"Mat Taib","year":"2021","unstructured":"Mat Taib, C. N., Mustapha, M. M. MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies. Bosn J Basic Med Sci. 21 (4), 422-433 (2021).","journal-title":"Bosn J Basic Med Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","type":"journal-article","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dion\u00edsio","year":"2021","unstructured":"Dion\u00edsio, P. A., Amaral, J. D., Rodrigues, C. M. P. Oxidative stress and regulated cell death in Parkinson's disease. Ageing Res Rev. 67, 101263 (2021).","journal-title":"Ageing Res Rev"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd.2018.136","type":"journal-article","article-title":"Therapeutic strategies for Parkinson disease: Beyond dopaminergic drugs","volume":"17","author":"Charvin","year":"2018","unstructured":"Charvin, D., Medori, R., Hauser, R. A., Rascol, O. Therapeutic strategies for Parkinson disease: Beyond dopaminergic drugs. Nat Rev Drug Discov. 17 (11), 804-822 (2018).","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.25634.1","type":"journal-article","article-title":"Recent developments in the treatment of Parkinson's disease","volume":"9","author":"Stoker","year":"2020","unstructured":"Stoker, T. B., Barker, R. A. Recent developments in the treatment of Parkinson's disease. F1000Res. 9, F1000 Faculty Rev-862 (2020).","journal-title":"F1000Res"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/S1353-8020(11)70045-1","type":"journal-article","article-title":"Neurorestoration","volume":"18 Suppl 1","author":"Airavaara","year":"2012","unstructured":"Airavaara, M., Voutilainen, M. H., Wang, Y., Hoffer, B. J. Neurorestoration. Parkinsonism Relat Disord. 18 Suppl 1(01), S143-S146 (2012).","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.80.11.3531","type":"journal-article","article-title":"Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors","volume":"80","author":"Guidotti","year":"1983","unstructured":"Guidotti, A. et al. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A. 80 (11), 3531-3535 (1983).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107386","DOI":"10.1016\/j.pharmthera.2019.06.008","type":"journal-article","article-title":"Endozepines and their receptors: Structure, functions and pathophysiological significance","volume":"208","author":"Tonon","year":"2020","unstructured":"Tonon, M. C. et al. Endozepines and their receptors: Structure, functions and pathophysiological significance. Pharmacol Ther. 208, 107386 (2020).","journal-title":"Pharmacol Ther"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00018-017-2727-2","type":"journal-article","article-title":"Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease","volume":"75","author":"Bahdoudi","year":"2018","unstructured":"Bahdoudi, S. et al. Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease. Cell Mol Life Sci. 75 (11), 2075-2091 (2018).","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"585082","DOI":"10.3389\/fendo.2020.585082","type":"journal-article","article-title":"Intranasal administration of PACAP is an efficient delivery route to reduce infarct volume and promote functional recovery after transient and permanent middle cerebral artery occlusion","volume":"11","author":"Cherait","year":"2021","unstructured":"Cherait, A., Maucotel, J., Lefranc, B., Leprince, J., Vaudry, D. Intranasal administration of PACAP is an efficient delivery route to reduce infarct volume and promote functional recovery after transient and permanent middle cerebral artery occlusion. Front Endocrinol. 11, 585082 (2021).","journal-title":"Front Endocrinol"},{"issue":"14","key":"ref10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/cells13141188","type":"journal-article","article-title":"promotes cell survival against 6-OHDA-induced oxidative stress and apoptosis by modulating the expression of miR-34b, miR-29a, and miR-21 in cultured astrocytes","volume":"13","author":"Bourzam","year":"2024","unstructured":"Bourzam, A. et al. Octadecaneuropeptide, ODN, promotes cell survival against 6-OHDA-induced oxidative stress and apoptosis by modulating the expression of miR-34b, miR-29a, and miR-21 in cultured astrocytes. Cells. 13 (14), 1188 (2024).","journal-title":"Cells"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.3390\/molecules24183310","type":"journal-article","article-title":"Octadecaneuropeptide (ODN) induces N2a cells differentiation through a PKA\/PLC\/PKC\/MEK\/ERK-dependent pathway: Incidence on peroxisome, mitochondria, and lipid profiles","volume":"24","author":"Namsi","year":"2019","unstructured":"Namsi, A. et al. Octadecaneuropeptide (ODN) induces N2a cells differentiation through a PKA\/PLC\/PKC\/MEK\/ERK-dependent pathway: Incidence on peroxisome, mitochondria, and lipid profiles. Molecules. 24 (18), 3310 (2019).","journal-title":"Molecules"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"566026","DOI":"10.3389\/fendo.2020.566026","type":"journal-article","article-title":"Cytoprotective and neurotrophic effects of octadecaneuropeptide (ODN) in in vitro and in vivo models of neurodegenerative diseases","volume":"11","author":"Masmoudi-Kouki","year":"2020","unstructured":"Masmoudi-Kouki, O. et al. Cytoprotective and neurotrophic effects of octadecaneuropeptide (ODN) in in vitro and in vivo models of neurodegenerative diseases. Front Endocrinol. 11, 566026 (2020).","journal-title":"Front Endocrinol"},{"issue":"7487","key":"ref13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature12880","type":"journal-article","article-title":"Intranasal epidermal growth factor treatment rescues neonatal brain injury","volume":"506","author":"Scafidi","year":"2014","unstructured":"Scafidi, J. et al. Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature. 506 (7487), 230-234 (2014).","journal-title":"Nature"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","type":"journal-article","article-title":"IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","unstructured":"Lopes, C. et al. IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice. Mol Neurobiol. 49 (3), 1126-1142 (2014).","journal-title":"Mol Neurobiol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.peptides.2012.05.021","type":"journal-article","article-title":"Intranasal administration of PACAP: Uptake by brain and brain region targeting with cyclodextrins","volume":"36","author":"Nonaka","year":"2012","unstructured":"Nonaka, N. et al. Intranasal administration of PACAP: Uptake by brain and brain region targeting with cyclodextrins. Peptides. 36 (2), 168-175 (2012).","journal-title":"Peptides"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","type":"journal-article","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","unstructured":"Illum, L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 11 (1), 1-18 (2000).","journal-title":"Eur J Pharm Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","type":"journal-article","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9 Suppl 3","author":"Hanson","year":"2008","unstructured":"Hanson, L. R., Frey, W. H. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9 Suppl 3, S5 (2008).","journal-title":"BMC Neurosci"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","type":"journal-article","article-title":"Intranasal delivery to the central nervous system: Mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","unstructured":"Dhuria, S. V., Hanson, L. R., Frey, W. H. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci. 99 (4), 1654-1673 (2010).","journal-title":"J Pharm Sci"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","type":"journal-article","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","unstructured":"Lochhead, J. J., Thorne, R. G. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 64 (7), 614-628 (2012).","journal-title":"Adv Drug Deliv Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-4939-9662-9_2","type":"journal-article","article-title":"Dissection of rodent brain regions: Guided free-hand slicing and dissection of frozen tissue","volume":"146","author":"Spijker","year":"2019","unstructured":"Spijker, S., Faliagkas, L., Rao-Ruiz, P. Dissection of rodent brain regions: Guided free-hand slicing and dissection of frozen tissue. Neuroproteomics. 146, 7-19 (2019).","journal-title":"Neuroproteomics"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"100290","DOI":"10.1016\/j.xpro.2020.100290","type":"journal-article","article-title":"Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models","volume":"2","author":"Eyme","year":"2021","unstructured":"Eyme, K. M., Carvalho, L., Badr, C. E. Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models. STAR Protoc. 2 (1), 100290 (2021).","journal-title":"STAR Protoc"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","type":"journal-article","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","unstructured":"Khan, A. R., Liu, M., Khan, M. W., Zhai, G. Progress in brain targeting drug delivery system by nasal route. J Controlled Release. 268, 364-389 (2017).","journal-title":"J Controlled Release"},{"issue":"143","key":"ref23","first-page":"e58653","type":"journal-article","article-title":"Behavioral assessments of spontaneous locomotion in a murine MPTP-induced Parkinson's disease model","author":"Jiang","year":"2019","unstructured":"Jiang, P. E. et al. Behavioral assessments of spontaneous locomotion in a murine MPTP-induced Parkinson's disease model. J Vis Exp. 143, e58653 (2019).","journal-title":"J Vis Exp"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jchromb.2015.11.052","type":"journal-article","article-title":"A step-by-step protocol for assaying protein carbonylation in biological samples","volume":"1019","author":"Colombo","year":"2016","unstructured":"Colombo, G. et al. A step-by-step protocol for assaying protein carbonylation in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci. 1019, 178-190 (2016).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","type":"journal-article","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","unstructured":"Misra, H. P., Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247 (10), 3170-3175 (1972).","journal-title":"J Biol Chem"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","type":"journal-article","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","unstructured":"Schmittgen, T. D., Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 3 (6), 1101-1108 (2008).","journal-title":"Nat Protoc"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","type":"journal-article","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis, V., Przedborski, S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc. 2 (1), 141-151 (2007).","journal-title":"Nat Protoc"},{"issue":"1-2","key":"ref28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","type":"journal-article","article-title":"Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats","volume":"255","author":"Dufes","year":"2003","unstructured":"Dufes, C., Olivier, J. C., Gaillard, F., Gaillard, A., Couet, W., Muller, J. M. Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Int J Pharm. 255 (1-2), 87-97 (2003).","journal-title":"Int J Pharm"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"751321","DOI":"10.3389\/fphar.2021.751321","type":"journal-article","article-title":"Encapsulated escitalopram and paroxetine intranasal co-administration: In vitro\/in vivo evaluation","volume":"12","author":"Silva","year":"2021","unstructured":"Silva, S. et al. Encapsulated escitalopram and paroxetine intranasal co-administration: In vitro\/in vivo evaluation. Front Pharmacol. 12, 751321 (2021).","journal-title":"Front Pharmacol"},{"issue":"8","key":"ref30","first-page":"2088","type":"journal-article","article-title":"Nose to brain transport pathways an overview: Potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2017","unstructured":"Selvaraj, K., Gowthamarajan, K., Karri, V. V. S. R. Nose to brain transport pathways an overview: Potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomedicine Biotechnol. 46 (8), 2088-2095 (2017).","journal-title":"Artif Cells Nanomedicine Biotechnol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","type":"journal-article","article-title":"Drug delivery to the brain via the nasal route of administration: Exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","unstructured":"Jeong, S. H., Jang, J. H., Lee, Y. B. Drug delivery to the brain via the nasal route of administration: Exploration of key targets and major consideration factors. J Pharm Investig. 53 (1), 119-152 (2023).","journal-title":"J Pharm Investig"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/pharmaceutics15082032","type":"journal-article","article-title":"The potential of the nose-to-brain delivery of PACAP for the treatment of neuronal disease","volume":"15","author":"Cherait","year":"2023","unstructured":"Cherait, A., Banks, W. A., Vaudry, D. The potential of the nose-to-brain delivery of PACAP for the treatment of neuronal disease. Pharmaceutics. 15 (8), 2032 (2023).","journal-title":"Pharmaceutics"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/pharmaceutics14030629","type":"journal-article","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","unstructured":"Crowe, T. P., Hsu, W. H. Evaluation of recent intranasal drug delivery systems to the central nervous system. Pharmaceutics. 14 (3), 629 (2022).","journal-title":"Pharmaceutics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","type":"journal-article","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9 Suppl 3","author":"Hanson","year":"2008","unstructured":"Hanson, L. R., Frey, W. H. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 9 Suppl 3, S5 (2008).","journal-title":"BMC Neurosci"},{"issue":"1","key":"ref35","first-page":"19","type":"journal-article","article-title":"MPTP mouse models of Parkinson's disease: An update","volume":"1","author":"Meredith","year":"2011","unstructured":"Meredith, G. E., Rademacher, D. J. MPTP mouse models of Parkinson's disease: An update. J Park Dis. 1 (1), 19-33 (2011).","journal-title":"J Park Dis"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1381612822666151112151653","type":"journal-article","article-title":"Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants","volume":"22","author":"Sarrafchi","year":"2016","unstructured":"Sarrafchi, A., Bahmani, M., Shirzad, H., Rafieian-Kopaei, M. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des. 22 (2), 238-246 (2016).","journal-title":"Curr Pharm Des"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","type":"journal-article","article-title":"Neuroinflammation in Parkinson's disease: A target for neuroprotection","volume":"8","author":"Hirsch","year":"2009","unstructured":"Hirsch, E. C., Hunot, S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol. 8 (4), 382-397 (2009).","journal-title":"Lancet Neurol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s11064-010-0212-5","type":"journal-article","article-title":"The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease","volume":"35","author":"Baillet","year":"2010","unstructured":"Baillet, A. et al. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res. 35 (10), 1530-1537 (2010).","journal-title":"Neurochem Res"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s11064-011-0471-9","type":"journal-article","article-title":"Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains","volume":"36","author":"Mythri","year":"2011","unstructured":"Mythri, R. B. et al. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochem Res. 36 (8), 1452-1463 (2011).","journal-title":"Neurochem Res"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","type":"journal-article","article-title":"Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: Implications for Parkinson's disease","volume":"37","author":"Venkateshappa","year":"2012","unstructured":"Venkateshappa, C. et al. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: Implications for Parkinson's disease. Neurochem Res. 37 (2), 358-369 (2012).","journal-title":"Neurochem Res"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1007\/s12035-017-0630-3","type":"journal-article","article-title":"Endogenous expression of ODN-related peptides in astrocytes contributes to cell protection against oxidative stress: Astrocyte-neuron crosstalk relevance for neuronal survival","volume":"55","author":"Ghouili","year":"2018","unstructured":"Ghouili, I. et al. Endogenous expression of ODN-related peptides in astrocytes contributes to cell protection against oxidative stress: Astrocyte-neuron crosstalk relevance for neuronal survival. Mol Neurobiol. 55 (6), 4596-4611 (2018).","journal-title":"Mol Neurobiol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-018-1181-4","type":"journal-article","article-title":"Antioxidant and anti-apoptotic activity of octadecaneuropeptide against 6-OHDA toxicity in cultured rat astrocytes","volume":"69","author":"Kaddour","year":"2019","unstructured":"Kaddour, H. et al. Antioxidant and anti-apoptotic activity of octadecaneuropeptide against 6-OHDA toxicity in cultured rat astrocytes. J Mol Neurosci MN. 69 (1), 1-16 (2019).","journal-title":"J Mol Neurosci MN"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68122\/neuroprotective-effects-intranasally-administered","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:35:59Z","timestamp":1792593359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68122\/neuroprotective-effects-intranasally-administered"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":42,"journal-issue":{"issue":"222","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68122","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}